Human T-cell lymphotropic virus type I infection in barbados: Results of a 20-year follow-up study

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 12, Issue 5, 1996, Pages 519-522

  Rabkin, Charles S ^a   Corbin, David O C ^b   Felton, Susanne ^c   Barker, Harriet ^b   Davison, Dorothy ^b   Dearden, Claire ^b   Blattner, William A ^a   Evans, Alfred S ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b QUEEN ELIZABETH HOSPITAL   (Barbados)

^c RTI INTERNATIONAL   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adult T cell leukemia; Chronic infection; Dermatitis; Follow up study; Household contact

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; DATA ANALYSIS; DISEASE ASSOCIATION; ENZYME IMMUNOASSAY; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOBLOTTING; INFECTION RISK; LYMPHOMA; MALE; PHLEBOTOMY; PRIORITY JOURNAL; RISK FACTOR; SERODIAGNOSIS; SPASTIC PARAPLEGIA; T CELL LEUKEMIA; VIRUS INFECTION;

HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LYMPHOTROPIC VIRUS TYPE I; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0029791488     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199608150-00013     Document Type: Article

References (17)

1. Blattner WA. Epidemiology of HTLV-I and associated diseases. In: Blattner WA, ed. Human retrovirology: HTLV. New York: Raven Press, 1990:251-65.
2. Morgan OS, Rodgers-Johnson P, Mora C, Char G. HTLV-I and polymyositis in Jamaica. Lancet 1989;2(8673):1184-7.
3. Ijichi S, Matsuda T, Maruyama I, et al. Arthritis in a human T lymphotropic virus type I (HTLV-I) carrier. Ann Rheum Dis 1990;49(4):718-21.
4. LaGrenade L, Hanchard B, Fletcher V, Cranston B, Blattner WA. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet 1990;336:1345-6.
5. Murphy EL, Figueroa JP, Gibbs WN, et al. Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinants. Am J Epidemiol 1991;133(11): 1114-24.
6. Riedel DA, Evans AS, Saxinger C, Blattner WA. A historical study of human T lymphotropic virus type I transmission in Barbados. J Infect Dis 1989;159:603-9.
7. Evans A, Cox F, Nankervis G, et al. A health and seroepidemiological survey of a community in Barbados, Int J Epidemiol 1974;3:167-75.
8. Evans AS, Wells AV, Ramsay F, Drabkin P, Palmer K. Poliomyelitis, rubella, and dengue antibody survey in Barbados: a follow-up study. Int J Epidemiol 1979;8:235-41.
9. Morofuji-Hirata M, Kajiyama W, Nakashima K, Noguchi A, Hayashi J, Kashiwagi S. Prevalence of antibody to human T-cell lymphotropic virus type I in Okinawa, Japan, after an interval of 9 years. Am J Epidemiol 1993;137:43-8.
10. Ueda K, Kusuhara K, Tokugawa K, et al. Mother-to-child transmission of human T-lymphotropic virus type I (HTLV-I): an extended follow-up study on children between 18 and 22-24 years old in Okinawa, Japan. Int J Cancer 1993;53: 597-600.
11. Ando Y, Tanigawa T, Ekuni Y, Ichijo M, Tohyama T. Family study of women showing development of antibody to human T-cell leukemia virus I and assessment of the risk of vertical transmission of the virus to their children. J Infect 1993;27:151-5.
12. Takezaki T, Tajima K, Komoda H, Imai J. Incidence of human T lymphotropic virus type I seroconversion after age 40 among Japanese residents in an area where the virus is endemic. J Infect Dis 1995;171:559-65.
13. Stuver SO, Tachibana N, Okayama A, et al. Heterosexual transmission of human T cell leukemia/lymphoma virus type I among married couples in southwestern Japan: an initial report from the Miyazaki Cohort Study. J Infect Dis 1993; 167:57-65.
14. Ho GYF, Nomura AMY, Nelson K, Lee H, Polk BF, Blattner WA. Declining seroprevalence and transmission of HTLV-I in Japanese families who immigrated to Hawaii. Am J Epidemiol 1991;134:981-7.
15. Jason J, Murphy J, Sleeper LA, et al. Immune and serologic profiles of HIV-infected and noninfected hemophilic children and adolescents: Hemophilia Growth and Development Study Group. Am J Hematol 1994;46:29-35.
16. Welles SL, Tachibana N, Okayama A, et al. Decreased reactivity to PPD among HTLV-I carriers in relation to virus and hematologic status. Int J Cancer 1994;56:337-40.
17. Ho GYF, Nelson K, Nomura AMY, Polk BF, Blattner WA. Markers of health status in an HTLV-I-positive cohort. Am J Epidemiol 1992;136(11):1349-57.